Perseus Proteomics (4882) Latest Earnings: Net Sales Increase by +49.9% YoY to 35 Million Yen

According to the latest financial data released by Perseus Proteomics (4882), net sales reached 35 million yen, representing a significant year-on-year increase of +49.9%. Meanwhile, regarding earnings performance, the company reported an operating loss of 204 million yen, an ordinary loss of 201 million yen, and a net loss of 202 million yen, reflecting ongoing upfront investments in research and development and business expansion. Earnings per share (EPS) stood at -11.85 yen.

From the perspective of financial structure and valuation metrics, the equity ratio remains high at 68.5%, indicating a solid financial foundation. Interest-bearing debt is 0.0 billion yen, maintaining a virtually debt-free status, while cash and cash equivalents stand at 1.52 billion yen, providing ample liquidity to support ongoing business activities for the foreseeable future. Operating cash flow was -0.65 billion yen, free cash flow was -0.66 billion yen, and retained earnings registered at -0.72 billion yen.